Spots Global Cancer Trial Database for acute graft versus host disease
Every month we try and update this database with for acute graft versus host disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation | NCT01882374 | Hematologic Mal... | TXA127 | 18 Years - | Tarix Pharmaceuticals | |
| Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies | NCT05443425 | Acute Graft Ver... Hematopoietic a... | Cholestyramine Leflunomide Steroid Therapy | 18 Years - | City of Hope Medical Center | |
| Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT) | NCT02194868 | Allogeneic Hema... | Recipients Donors | - | Assistance Publique - Hôpitaux de Paris | |
| CINC424A2X01B Rollover Protocol | NCT02386800 | Primary Myelofi... Polycythemia Ve... Graft Versus Ho... Acute Myeloid L... Thalassemia | ruxolitinib panobinostat | 1 Month - | Novartis | |
| Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation | NCT01882374 | Hematologic Mal... | TXA127 | 18 Years - | Tarix Pharmaceuticals | |
| Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT) | NCT02194868 | Allogeneic Hema... | Recipients Donors | - | Assistance Publique - Hôpitaux de Paris | |
| Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005) | NCT04095858 | Hematopoietic S... Acute Graft Ver... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... | Efprezimod alfa Placebo Methotrexate Tacrolimus | 18 Years - | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies | NCT05443425 | Acute Graft Ver... Hematopoietic a... | Cholestyramine Leflunomide Steroid Therapy | 18 Years - | City of Hope Medical Center | |
| Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation | NCT06026371 | Acute Graft Ver... Hematopoietic a... | Fecal Microbiot... Placebo | 18 Years - | Fred Hutchinson Cancer Center | |
| Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections | NCT02805946 | Allogeneic Stem... Acute Graft Ver... Acute Myeloid L... Myelo Dysplasti... | posaconazole | 18 Years - | Radboud University Medical Center | |
| Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT) | NCT02194868 | Allogeneic Hema... | Recipients Donors | - | Assistance Publique - Hôpitaux de Paris | |
| Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT) | NCT02194868 | Allogeneic Hema... | Recipients Donors | - | Assistance Publique - Hôpitaux de Paris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
